We are live on
!
Find out more
IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
31 hedge funds and large institutions have $6.26M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
3% less funds holding
Funds holding: 32 → 31 (-1)
17% less capital invested
Capital invested by funds: $7.54M → $6.26M (-$1.28M)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
6
Closed
5
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$2K
Top Buyers
| 1 |
B
Bailard
Foster City,
California
|
+$622K |
| 2 |
Renaissance Technologies
New York
|
+$605K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$145K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$29.1K |
